Elucidating the mechanism(s) of hormesis at the cellular level: The universal cell response

American Journal of Pharmacology and Toxicology

Volumn 3, Issue 1, 2008, Pages 97-107

  Agutter, Paul S ^a  

^a Theoretical and Cell Biology Consultancy   (United Kingdom)

Author keywords

Cellular homeostasis; Law of mass action; Universal cell response

Indexed keywords

ADAPTATION; ARTICLE; CELL ACTIVITY; CELL GROWTH; CELL LEVEL; CELL METABOLISM; CELL VIABILITY; CONCENTRATION RESPONSE; ENVIRONMENTAL STRESS; GROWTH REGULATION; HOMEOSTASIS; HORMESIS; HUMAN; LIGAND BINDING; MASS ACTION; MOLECULAR INTERACTION; NONHUMAN; RELIABILITY;

EID: 52949104005     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2008.100.110     Document Type: Article

References (63)

1. Morré, D.J., 2000. Chemical hormesis in cell growth: A molecular target at the cell surface. J. Appl. Toxicol., 20: 157-163.
2. Forbes, V.E., 2000. Is hormesis an evolutionary expectation? Fuct. Ecol., 14: 12-24.
3. Rozman, K.K. and J. Doull, 2003. Scientific foundations of hormesis. Part 2. Maturation, strengths, limitations and possible applications in toxicology, pharmacology and epidemiology. Crit. Rev. Toxicol., 33: 451-462.
4. Calabrese, E.J., 2005. Paradigm lost, paradigm found: The re-emergence of hormesis as a fundamental dose response model in the toxicological sciences. Environ. Pollut., 138: 379-411.
5. Calabrese, E.J., J.W. Staudenmeyer and E.J. Stanek, 2006. Drug development and hormesis: Changing conceptual understanding of the dose response creates new challenges and opportunities for more effective drugs. Curr. Opin. Drug. Discovery Dev., 9: 117-123.
6. Calabrese, E.J. and L.A. Baldwin, 2001. The frequency of U-shaped dose responses in the toxicological literature. Toxicol. Sci., 62: 330-338.
7. Calabrese, E.J., J.W. Staudenmeyer, E.J. Stanek III and G.R. Hoffmann, 2006. Hormesis outperforms threshold model in National Cancer Institute antitumor drug screening database. Toxicol. Sci., 94: 368-378.
8. Cedergreen, N., C. Ritz and J.C. Streibig, 2005. Improved empirical models describing hormesis. Envir. Toxicol. Chem., 24: 3166-3172.
9. May, S. and C. Bigelow, 2005. Modeling nonlinear dose-response relationships in epidemiologic studies: statistical approaches and practical challenges. Dose-Response, 3: 474-490.
10. Stebbing, A.R.D., 2000. Hormesis: interpreting the beta curve using control theory. J. Appl. Toxicol., 20: 93-101.
11. Stebbing, A.R.D., 2003. A mechanism for hormesis - a problem in the wrong discipline. Crit. Rev. Toxicol., 33: 463-467.
12. Kitchin, K.T., 2002. Defining, explaining and understanding hormesis. Hum. Exp. Toxicol., 21: 91-97.
13. Calabrese, E.J., K.A. Bachmann, A.J. Bailer, P.M. Bolger, J. Borak, L. Cai, N. Cedergreen, M.G. Cherian, C.C. Chiueh, T.W. Clarkson, P.R. Cook, D.M. Diamond, D.J. Doolittle, M.A. Dorato, S.O. Duke, L. Feinendegen, D.E. Gardner, R.W. Hart, K.L. Hastings, A.W. Hayes, G.R. Hoffmann, J.A. Ives, Z. Jaworowski, T.E. Johnson, W.B. Jonas, N.E. Kaminski, J.G. Keller, J.E. Klaunig, T.B. Knudsen, W.J. Kozumbo, T. Lettieri, S.Z. Liu, A. Maisseu, K.I. Maynard, E.J. Masoro, R.O. McClellan, H.M. Mehendale, C. Mothersill, D.B. Newlin, H.N. Nigg, F.W. Oehme, R.F. Phalen, M.A. Philbert, S.I. Rattan, J.E. Riviere, J. Rodricks, R.M. Sapolsky, B.R. Scott, C. Seymour, D.A. Sinclair, J. Smith-Sonneborn, E.T. Snow, L. Spear, D.E. Stevenson, Y. Thomas, M. Tubiana, G.M. Williams and M.P. Mattson, 2007. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol. Appl. Pharmacol., 222: 122-128.
14. Calabrese, E.J. and L.S. Baldwin, 1997. Chemical Hormesis: Scientific Foundations, Documentation and Implications for Risk Assessment. School of Public Health, Environmental Health Sciences, University of Massachusetts, Amherst, MA.
15. Connolly, R.B. and W.K. Lutz, 2004. Nonmonotonic dose-response relationships: Mechanistic basis, kinetic modeling and implications for risk assessment. Toxicol. Sci., 77: 151-157.
16. Townsend, J.F. and T.D. Luckey, 1960. Hormoligosis in pharmacology. JAMA., 173: 44-48.
17. Gurevich, K.G., 2001. Low doses of biologically active substances: effects, possible mechanisms and features. Cell Biol. Internat., 25: 475-484.
18. Gurevich, K.G., P.S. Agutter and D.N. Wheatley, 2003. Stochastic description of the ligand-receptor interaction of biologically active substances as extremely low doses. Cell Signalling, 15: 447-453.
19. Stebbing, A.R.D., J.P. Norton and M.D. Brinsley, 1984. Dynamics of growth control in a marine yeast subjected to perturbation. J. Gen. Microbiol., 130: 1799-1808.
20. Leinders-Zufall, T., A.P. Lane, A.C. Puche, W. Ma, M.V. Novotny, M.T. Shipley and F. Zufall, 2000. Ultrasensitive pheromone detection by mammalian vomeronasal neurons. Nature, 405: 792-796.
21. Williamson, S.A., R.A. Knight, S.L. Lightman and J.R. Hobbs, 1987. Differential effects of beta-endorphin fragments on human natural killing. Brain Behav. Immunol., 1: 329-335.
22. Szabadi, E., 1977. Model of 2 functionally antagonistic receptor populations activated by same agonist. J. Theor. Biol., 69: 101-112.
23. Norgaard. R., M. Kassem and S.I.S. Rattan, 2006. Heat shock-induced enhancement of osteoblastic differentiation of hTERT-immortalized mesenchymal stem cells. Ann. N.Y. Acad. Sci., 1067: 443-447.
24. Rattan, S.I.S., 2005. Hormetic modulation of aging and longevity by mild heat stress. Dose Response, 3: 533-546.
25. Rattan, S.I.S. and B.F.C. Clark, 2005. Understanding and modulating aging. Life, 57: 297-304.
26. Kyriazis, M., 2005. Clinical anti-aging hormetic strategies. Rejuvenat. Res., 8: 96-100.
27. Fonager, J., R. Beedholm, B.F.C. Clark and S.I.S. Rattan, 2002. Mild stress-induced stimulation of heat-shock protein synthesis and improved functional ability of human fibroblasts undergoing aging in vitro. Exp. Gerontol., 37: 1223-1228.
28. Verbeke, P., B.F.C. Clark and S.I.S. Rattan, 2000. Modulating cellular aging in vitro: hormetic effects of repeated mild heat stress on protein oxidation and glycation. Exp. Gerontol., 35:.787-794.
29. Randic, M. and E. Estrada, 2005. Order from chaos: Observing hormesis at the proteome level. J. Proteome Res., 4: 2133-2136.
30. Nasonov, D.N., 1962. Local Reaction of Protoplasm and Gradual Excitation (English Translation by Halpern, Y.S.). National Science Foundation, Washington DC. Available from the Office of Technical Services, US Department of Commerce.
31. Aguttef, P.S., 2007. Cell mechanics and stress: From molecular details to the universal cell response and hormesis. BioEssays, 29: 324-333.
32. Eïdus, L.Kh., 2005. On the mechanism of the nonspecific cell response to the action of dainaging agents and the nature of hormesis. Biofizika, 50: 693-703.
33. Matveev, V.V., 2005. Protoreaction of protoplasm. Cell. Mol. Biol., 51: 715-723.
34. Franks, N.P. and E. Honore, 2004. The TREK K2P channels and their role in general anaesthesia and neuroprotection. Trends Pharmacol. Sci., 35: 601-608.
35. Franks, N.P., 2006. Molecular targets underlying general anaesthesia. Br. J. Pharmacol., 147: S72-81.
36. Arumugam, T.V., M. Gleichmann, S.C. Tang and M.P. Mattson, 2006. Hormesis/preconditioning mechanisms, the nervous system and aging. Ageing Res. Rev., 5: 165-178.
37. Rohrbach, S., B. Niemann, A.M. Abushouk and J. Holtz, 2006. Caloric restriction and mitochondrial function in the ageing myocardium. Exp. Gerontol., 41: 525-531.
38. Eïdus, L.Kh., 1994. The mechanism of the initiation of low-dose effects. Radiats. Biol. Radioecol., 34: 748-758.
39. Eïdus, L.Kh., 1996. A single mechanism for the initiation of different effects of low doses of ionizing radiation. Radiat. Biol. Radioecol., 36: 874-882.
40. Eïdus, L.Kh. and V.L. Eïdus, 2001. Problems of the mechanism of radiation and chemical hormesis. Radiats. Biol. Radioecol., 41: 627-630.
41. Eïdus, L.Kh., 1997. Is apoptosis a programmed cell death? Radiats. Biol. Radioecol., 37: 527-532.
42. Agutter, P.S. and D.N. Wheatley, 2007. About Life: Concepts in Modem Biology. Springer Dordrecht, pp: 91-103.
43. Stebbing, A.R.D., 1998. A theory for growth hormesis. Mutat. Res.. 403: 249-259.
44. Selye, H, 1946. The general adaptation syndrome and the diseases of adaptation. J. Clin. Endocrinol., 6: 117-231.
45. Goldstein, D.S. and I.J. Kopin, 2007. Evolution of concepts of stress. Stress, 10: 109-120.
46. Arumugam, T.V., M. Gleichmann, S.C. Tang and Mattson, 2006. Hormesis/ Preconditioning mechanisms, the nervous system and aging. Ageing Res. Rev., 5: 165-178.
47. Daitoku, H. and A. Fukamizu, 2007. FOXO transcription factors in the regulatory networks of longevity. J. Biochem. (Tokyo), 141: 769-774.
48. Stebbing, A.R.D., 1987. Growth hormesis: A byproduct of control. Health Phys., 52: 543-547.
49. Stebbing, A.R.D., 2003. Adaptive responses account for the β-curve - hormesis is linked to acquired tolerance. Nonlinearity Biol. Tox. Med., 1: 493-511.
50. Calabrese, E.J. and L.A. Baldwin, 2001. Hormesis: A generalizable and unifying hypothesis. Crit. Rev. Toxicol., 31: 353-424.
51. Calabrese, E.J., 2001. Overcompensation stimulation: A mechanism for hormetic effects. Crit. Rev. Toxicol., 31: 425-470.
52. Fabrikant, J.I., 1987. Adaptation of cell renewal systems under continuous irradiation. Health Phys., 52: 561-570.
53. Cox, L.A., 2005. A model of cytotoxic dose-response nonlinearities arising from adaptive cell inventory management in tissues. Dose-Response, 3: 491-507.
54. Van der Woude, H., G.M. Alink and I.M.C.M. Rietjens, 2005. The definition of hormesis and its implications for in vitro to in vivo extrapolation and risk assessment. Crit. Rev. Toxicol., 35: 603-607.
55. Lutz, W.K., S. Vamvakas, A. Kopp-Schneider, J. Schlatter and H. Stopper, 2002. Deviation from additivity in mixture toxicity: relevance of nonlinear dose-response relationships and cell line differences in genotoxicity assays with combinations of chemical mutagens and gamma-radiation. Environ. Health Perspect., 110: 915-918.
56. Philip K. Drinker, 1938. Carbon monoxide asphyxia. Oxford University Press, New York, pp: 124 ff.
57. Wilhelm F. van Ottingen, 1941. Studies on the mechanism of carbon monoxide poisoning as observed in dogs anesthetized with sodium amytal. United States Public Health Service, Washington DC.
58. Malone, P.C. and P.S. Agutter, 2006. The aetiology of deep venous thrombosis. Quart. J. Med., 99: 581-593.
59. Fujita, T., K. Toda, A. Karimova, S.F. Yan, U. Naka, S.F. Yet and D.J. Pinsky, 2001. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nature Med., 7: 597-604.
60. Mishra, S., T. Fujita, V.N. Lama, D. Nam, H. Liao, M. Okada, K. Minamoto, Y. Yoshikawa, H. Harada, H. and D.J. Pinsky, 2006. Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc. Natl. Acad. Sci. USA, 103: 5191-5196.
61. Lutz, W.K. 2000. A true threshold dose in chemical carcinogenesis cannot be defined for a population, irrespective of the mode of action. Hum. Exp. Toxicol., 19: 566-568.
62. Lutz, W.K., 2002. Differences in individual susceptibility to toxic effects of chemicals determine the dose-response relationship and consequences of setting exposure standards. Toxicol. Lett., 126: 155-158.
63. Lutz, W.K., O. Tiedge, R.W. Lutz and H. Stopper, 2005. Different types of combination effects for the induction of micronuclei in mouse lymphoma cells by binary mixtures of the genotoxic agents MMS, MNU and genistein. Toxicol. Sci., 86: 318-323.